UBS Group’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

UBS Group’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10	Closed	-$3	–	10353
2024 Q1	$3	Buy	+10	New	+$3	﹤0.01%	9175
2023 Q3	–	Sell	-1,849	Closed	-$250	–	10153
2023 Q2	$250	Sell	1,849 -616	-25%	-$51	﹤0.01%	8352
2023 Q1	$123	Buy	+2,465	New	+$167	﹤0.01%	9205
2022 Q4	–	Sell	-11,412	Closed	-$1K	–	11338
2022 Q3	$1K	Buy	11,412 +300	+3%	+$29	﹤0.01%	10114
2022 Q2	$3K	Sell	11,112 -2,000	-15%	-$442	﹤0.01%	9401
2022 Q1	$5K	Buy	13,112 +12,800	+4,103%	+$5.83K	﹤0.01%	9194
2021 Q4	$0	Sell	312 -668	-68%	-$448	﹤0.01%	10891
2021 Q3	$1K	Buy	+980	New	+$783	﹤0.01%	9289

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 31.84% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group's AONCW Position: Q2 2024 in Review

UBS Group sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 10 shares — an estimated $3 sold.

UBS Group first reported a position in AONCW in Q3 2021 and held it in 8 quarters. The position peaked at $5K in Q1 2022. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

UBS Group reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
UBS Group sold 10 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $3.
UBS Group first reported a position in American Oncology Network, Inc. Warrant in Q3 2021 and held it in 8 quarters.
UBS Group's American Oncology Network, Inc. Warrant position peaked at $5K in Q1 2022.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.